A pill to prevent diabetes?

While much medical advancement have been made through the years, proper diet and regular exercise are still imperative and best for people with diabetes, but for the blood pricking, a new research proved an implantable artificial pancreas capable of controlling the patients’ blood sugar. Now scientists have raised an unusual question.

Type 1 diabetes is a chronic condition in which pancreas are being attacked and damaged by the immune system.

To qualify, subjects must have lab tests that show they’re at risk for developing Type 1 diabetes. It affects a little over 1 million Americans and is increasing worldwide for unknown reasons.

“Personally I do think that further personnel with class one- diabetes can indeed be healed with an production of glucose pump provided accuire all the most appropriate learning concerning the pump able to realize how to make use of it”, the woman instructed Reuter’s Health enduring an… Thereafter, it stimulates the release of required level of insulin.

In their study, the researchers detail the creation of a fully implantable artificial pancreas that uses an algorithm to monitor patients’ blood glucose levels and calculate the insulin dose needed, which is then automatically delivered to the body.

Francis J Doyle III and colleagues wanted to find a way to make monitoring and insulin delivery automatic and needle-free.

The only issue with these methods was that they lagged between when a dose is needed and when it starts showing effect in a person’s body, said researchers.

Researchers said the algorithm is exclusively created to work with implanted devices, specifically with an artificial pancreas. The diet would be carb-conscious; exercise should be monitored as well as those irritating periodical blood pricks to ensure blood glucose levels are still in tolerable levels.

The algorithm simulated the rise and fall of glucose levels in the body that would go through normal parts of the day, e.g. meals and sleep. It maintained blood sugar levels within a target range nearly 80 percent of the time. They hope to begin testing the device in animals in the near future.